Company Filing History:
Years Active: 2013
Title: Jim Swann: Innovator in Pharmaceutical Combinations
Introduction
Jim Swann is a notable inventor based in Waterloo, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents, his work focuses on combining non-steroidal anti-inflammatory agents with acetaminophen.
Latest Patents
Swann's latest patents include formulations that combine acetaminophen and ibuprofen. These pharmaceutical dosage forms are designed to provide effective pain relief by utilizing a specific weight ratio of about 12 parts ibuprofen to about 88 parts acetaminophen. This innovative approach aims to enhance the therapeutic effects of both agents while minimizing potential side effects.
Career Highlights
Throughout his career, Jim Swann has worked with prominent companies in the pharmaceutical industry, including McNeil-PPC, Inc. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.
Collaborations
One of his notable collaborators is Peter Cummins, with whom he has worked on various projects related to pharmaceutical innovations.
Conclusion
Jim Swann's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving pain management solutions. His work continues to influence the development of effective medication combinations.